21/07/2025 - Events
The project aims to determine the prognostic value of molecules in the tumor microenvironment in melanoma. A project led by Dr. Sònia Segura, attending physician in the Dermatology Department at Hospital del Mar and researcher in the Dermatological Inflammatory and Neoplastic Diseases Research Group at the Hospital del Mar Research Institute, has received one of the Jané Mateu Foundation grants in its third edition. The award ceremony took place on June 25 at the modernist site of Hospital de Sant Pau. The study aims to determine the prognostic value of molecules in the tumor microenvironment in melanoma, specifically a marker related to activation of the TGF-beta pathway, which is associated with the disease's ability to evade the immune system.
Més informació "The Jané Mateu Foundation Awards a Grant to a Project Led by Dr. Sònia Segura"
16/07/2025 - Press release
These molecules act as small building blocks that regulate the cellular response by switching certain internal signals on or off. This is the conclusion of an international study led by the Hospital del Mar Research Institute, published in the journal Nature Communications. The findings may help develop more precise drugs to treat various diseases more effectively, while avoiding side effects.
Més informació "Amino acids play a key role in how cells respond to drugs"
15/07/2025 - Events
The first collaboration day between the Hospital del Mar Research Institute and the Institute for Bioengineering of Catalonia (IBEC) was held today at the Barcelona Biomedical Research Park (PRBB). The meeting provided an opportunity to share research projects, identify areas for collaboration and formalise a strategic alliance through the signing of a collaboration agreement between the Hospital del Mar and the Hospital del Mar Research Institute and IBEC.
Més informació "Hospital del Mar and IBEC formalise a new collaboration"
10/07/2025 - Press release
The journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central factor in their ability to generate breast cancer metastasis. This molecule allows cancer cells to survive the most critical and challenging stage of metastasis-when they first reach a new organ-by evading immune system attacks. At the same time, it may serve as a marker of poor prognosis and metastasis risk in patients with TIM-3-positive tumors. This discovery opens the door to the potential use of treatments that block TIM-3 to prevent metastasis before it becomes clinically evident.
02/07/2025 - General information
Levels of butyrate and isobutyrate, short-chain fatty acids produced by the gut microbiota, are associated with a higher risk of developing the disease, according to a study led by IISPV and Hospital del Mar. A research team led by scientists from the Pere Virgili Health Research Institute (IISPV), the Hospital del Mar Research Institute, and the Diabetes and Associated Metabolic Diseases area of the CIBER (CIBERDEM) has identified two compounds present in the blood - butyrate and isobutyrate - that could serve as early predictors of type 2 diabetes in seemingly healthy individuals.
30/06/2025 - General information
The Health Services Research Group at the Hospital del Mar Research Institute of Barcelona (HMRIB) is leading the INSTRUMENTAL project, in collaboration with the General Subdirectorate of Addictions, HIV and Viral Hepatitis (SGAVIHV). The project aims to generate relevant and applicable knowledge about the mental health measurement instruments used in general population studies. This pioneering initiative seeks to optimize how population mental health is assessed.
27/06/2025 - Press release
A study by the Hospital del Mar Research Institute, recently published in the journal PNAS, advances our understanding of how the brain makes decisions by participating in the storage of associations between different stimuli. The research has identified the importance of specific brain areas in these processes, particularly the amygdala and its relationship with parts of the cerebral cortex. This finding could lead to new therapeutic approaches for treating mental disorders such as psychosis or post-traumatic stress disorder (PTSD). The study was conducted on mice, but the researchers believe that the mechanisms involved may be similar in humans.
Més informació "Understanding How the Brain Makes Decisions"
27/06/2025 - General information
Dr. Alicia Prieto, researcher at the Heart Disease Research Group of the Hospital del Mar Research Institute of Barcelona (HMRIB) and cardiologist at Hospital del Mar, has been awarded one of the three Daniel Bravo Foundation Fellowships to carry out advanced research in cardiology at leading international centers, including the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).
20/06/2025 - Press release
People with Chronic Obstructive Pulmonary Disease (COPD) who suffer from sarcopenia, or loss of muscle capacity, have higher levels of a protein called myostatin, which, under normal conditions, helps regulate muscle growth. Elevated levels of this protein trigger a series of reactions in the muscle cells, preventing regeneration and growth after damage, leading to muscle mass loss in these patients. This was revealed by a study from the Hospital del Mar and the Hospital del Mar Research Institute, which opens the door to developing treatments targeted at this protein to reverse this situation.
Més informació "Researchers Discover the Cause of Muscle Loss in Some COPD Patients"
16/06/2025 - General information
The Head of the Gastrointestinal Surgery Unit of the General Surgery Department and researcher at the Hospital del Mar Research Institute had been a corresponding academic since 2024. On June 15, Dr. Manuel Pera, Head of the Gastrointestinal Surgery Unit at Hospital del Mar and researcher at its research institute, was appointed as a full academic member of the Royal Academy of Medicine of Catalonia. He now becomes one of the sixty full academic members of the institution, replacing Professor Lluís Morales i Fochs. The ceremony was sponsored by Professor Carmen Gomar and Professor Laureano Fernández-Cruz.
Més informació "Dr. Manuel Pera is now a full member of the Royal Academy of Medicine of Catalonia"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
